Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
28.7M
-
Shares change
-
+17.2M
-
Total reported value, excl. options
-
$2.39B
-
Value change
-
+$1.45B
-
Put/Call ratio
-
1.18
-
Number of buys
-
162
-
Number of sells
-
-41
-
Price
-
$83.35
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2020
242 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2020.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.7M shares
of 162M outstanding shares and own 17.72% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.76M shares), VANGUARD GROUP INC (4.64M shares), BlackRock Inc. (4.59M shares), STATE STREET CORP (2.31M shares), D. E. Shaw & Co., Inc. (995K shares), GEODE CAPITAL MANAGEMENT, LLC (900K shares), CITADEL ADVISORS LLC (780K shares), NORTHERN TRUST CORP (708K shares), CITIGROUP INC (654K shares), and Rock Springs Capital Management LP (571K shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.